SCHEMBL7973869

SCHEMBL7973869

O=c1[nH]c(-c2ccc(F)cc2)nc2ncn(CCc3ccccc3)c12

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
PARP2 Q9UGN5 1/20 0.46
CNOT7 Q9UIV1 5/20 0.45
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.40
BLM P54132 1/20 0.40
PLEC Q15149 1/20 0.40
PDE5A O76074 1/20 0.39
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985608 0.94 LMNA (0.53) TNKSTNKS2PARP2CNOT7LMNA
SCHEMBL7974613 0.92 CNOT7 (0.49) CNOT7LMNAKDM4EPOLBMAPK1
SCHEMBL7974505 0.89 SMN1; SMN2 (0.55) TNKSTNKS2PARP2CNOT7LMNA
SCHEMBL7984680 0.88 CNOT7 (0.43) CNOT7LMNAKDM4EPOLBMAPK1
SCHEMBL7991672 0.88 CNOT7 (0.46) CNOT7LMNAKDM4EPOLBMAPK1
SCHEMBL7984240 0.85 LMNA (0.58) CNOT7LMNAKDM4EPOLBMAPK1
SCHEMBL7974274 0.84 CNOT7 (0.45) CNOT7LMNAKDM4EPOLBMAPK1
SCHEMBL7986518 0.84 SMN1; SMN2 (0.53) TNKSTNKS2PARP2CNOT7LMNA
SCHEMBL7984488 0.83 LMNA (0.53) TNKSTNKS2CNOT7LMNAKDM4E
SCHEMBL7986324 0.83 HPGD (0.48) CNOT7LMNAKDM4EPOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed